Mabt
Manufacturing · Pennsylvania, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
3805 Old Easton Rd, Doylestown, Pennsylv...Website
www.mabt.usRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Mabt
Mid-Atlantic BioTherapeutics (MABT) is dedicated to advancing innovative therapies for challenging neurological and infectious diseases, including Alzheimer's, Parkinson's, and ALS. The company recently acquired XPose Therapeutics to enhance its oncology pipeline, focusing on breakthrough treatments for difficult-to-treat cancers. MABT leverages biotechnology and artificial intelligence to develop novel therapies, aiming to address unmet medical needs and improve patient outcomes. Founded in 2011, MABT is committed to compassionate innovation and transforming lives through its scientific advancements.Explore more
Mabt Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Mabt your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Mabt has new funding data
Earning: See what the market has to say on Mabt recently announced quarterly report
Product Launch: Get notified when Mabt launches new products
Click to see if Mabt had a recent Job posting/layoffs
Check if Mabt has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Mabt
Check out if Mabt is spiking on competitors!
Website visits: Recent activity has been detected on your website
Mabt, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Mabt
Compare insights from companies similar to Mabt, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Mabt is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Mabt is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Mabt.
Mabt financials insights
Gather financial insights about Mabt, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2025
Other Financing Round
$50M
Mabt Tech Stack
A closer look at the technologies used by Mabt
See more technologies
Mabt News & Media
Legend Innovation Life Science Fund Announces Investment Commitment of Up to $50 Million in Mid-Atlantic BioTherapeutics, Inc.
The investment will support MABT's continued clinical development, research initiatives, and regulatory milestones. The first funding tranche is expected in Q3 2025, marking a new chapter of growth for the company. MABT plans to initiate Phase 3 clinical trial for its lead viral...Legend Innovation Life Science Fund, LLC and Mid-Atlantic BioTherapeutics, Inc. Announce Plans for Biotech Facility in Songdo, Incheon
Legend Innovation Life Science Fund, LLC and Mid-Atlantic BioTherapeutics, Inc. are pleased to announce their ongoing collaboration to establish a state-of-the-art biotechnology research and production facility in Songdo, Incheon, South Korea. FORT LEE, N.J., Aug. 9, 2025...Mid-Atlantic BioTherapeutics, Inc. Launches $5 Million Regulation D 506(c) Funding Round ...
DOYLESTOWN, Pa., Oct. 15, 2024 /PRNewswire/ -- Mid-Atlantic BioTherapeutics, Inc. (the "Company"), a clinical-stage biotechnology company specializing in cutting-edge immunotherapies and central nervous system ("CNS") disorder treatments, today announced theMid-Atlantic BioTherapeutics, Inc. Launches $5 Million Regulation D 506(c) Funding Round to Support Clinical Program Acceleration and Expand the Company's Global Reach and Market Presence
DOYLESTOWN, Pa., Oct. 15, 2024 /PRNewswire/ -- Mid-Atlantic BioTherapeutics, Inc. (the "Company"), a clinical-stage biotechnology company specializing in cutting-edge immunotherapies and central nervous system ("CNS") disorder treatments, today announced the commencement of a fundraising...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Mabt
Sign Up For FreeTo access detailed company insights
Mid-Atlantic BioTherapeutics (MABT) is dedicated to advancing innovative therapies for challenging neurological and infectious diseases, including Alzheimer's, Parkinson's, and ALS. The company recently acquired XPose Therapeutics to enhance its oncology pipeline, focusing on breakthrough treatments for difficult-to-treat cancers. MABT leverages bi... Read More
